Dr. Michael Knable
Add to your Care-Team
Dr. Michael Knable
Dr. Michael Knable
I specialize in
I have been in practice
I'm known for
My answers and insights have
Helped 80 people
Received 2 doctor agrees
Here are kind words from others
This Thanksgiving, I wanted to share my appreciation for all that you do! Thank you, doctor! :)
I am located at
1904 R Street NW
Wichita , DC 20009
1904 R Street NW
Washington , DC 20009
4300 Mongtomery Avenue
Bethesda , MD 20814
Accepted Insurance Plans
I was educated and trained at
Medical / Graduate School
Ohio University College of Osteopathic Medicine
Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays.
BMC Psychiatry., 8:87 (2008)
Meta-analysis of 12 genomic studies in bipolar disorder.
J. Mol. Neurosci., 31(3):221-43 (2007)
Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts.
Biol. Psychiatry., Jul;58(2):85-96 (2005)
Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.
Biol. Psychiatry., Feb;57(3):252-60 (2005)
Secretin for refractory schizophrenia.
Schizophr. Res., Feb;66(2-3):177-81 (2004)
Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium.
Mol. Psychiatry., Jun;9(6):609-20, 544 (2004)
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.
Mol. Psychiatry., 7(9):985-94, 924 (2002)
Controlled trial of hydroxychloroquine in schizophrenia.
J Clin Psychopharmacol., Oct;22(5):507-10 (2002)
Extract of Ginkgo biloba added to haloperidol was effective for positive symptoms in refractory schizophrenia.
Evid Based Ment Health., Aug;5(3):90 (2002)
Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers.
Mol. Psychiatry., 7(4):392-404 (2002)
Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression.
Brain Behav. Immun., Dec;15(4):388-400 (2001)
Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium.
Brain Res. Bull., Jul;55(5):651-9 (2001)
Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder.
Prog. Neuropsychopharmacol. Biol. Psychiatry., Aug;24(6):881-8 (2000)
Schizophrenia and bipolar disorder: findings from studies of the Stanley Foundation Brain Collection.
Schizophr. Res., Sep;39(2):149-52; discussion 163 (1999)
In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine.
Psychiatry Res., Apr;90(2):81-90 (1999)
Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia.
Neurosci. Lett., Nov;257(2):65-8 (1998)
Reduced central serotonin transporters in alcoholism.
Am J Psychiatry., Nov;155(11):1544-9 (1998)
Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity.
Neurology., Oct;51(4):1069-74 (1998)
Psychomotor slowing, negative symptoms and dopamine receptor availability--an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients.
Schizophr. Res., May;31(1):19-26 (1998)
Schizophrenia as a developmental disorder of the cerebral cortex.
Curr. Opin. Neurobiol., Feb;8(1):157-61 (1998)
Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. [123I]-iodobenzamide SPECT study.
Br J Psychiatry., Dec;171:574-7 (1997)
Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia.
Neuropsychopharmacology., Mar;18(3):186-96 (1998)
Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels.
Psychiatry Res., Sep;75(2):91-101 (1997)
Analysis of the metabolites of [I-123] beta-CIT in plasma of human and nonhuman primates.
Synapse., Mar;25(3):306-8 (1997)
Dopamine, the prefrontal cortex and schizophrenia.
J. Psychopharmacol. (Oxford)., 11(2):123-31 (1997)
A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls.
Biol. Psychiatry., Dec;40(12):1191-9 (1996)
An improved method for rapid and efficient radioiodination of iodine-123-IQNB.
J. Nucl. Med., Dec;37(12):2021-4 (1996)
Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.
Am J Psychiatry., Dec;153(12):1571-8 (1996)
Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex.
Synapse., Nov;24(3):224-32 (1996)
Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding.
Science., Aug;273(5279):1225-7 (1996)
Dopamine D2 receptor imaging and neuroleptic drug response.
J Clin Psychiatry., 57 Suppl 11:84-8; discussion 89-93 (1996)
Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.
J. Neurosci., Mar;15(3 Pt 2):2186-91 (1995)
Are mental diseases brain diseases? The contribution of neuropathology to understanding of schizophrenic psychoses.
Eur Arch Psychiatry Clin Neurosci., 245(4-5):224-30 (1995)
Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients.
Biol. Psychiatry., Dec;36(12):827-35 (1994)
Limbic-prefrontal connectivity and clozapine.
J Clin Psychiatry., Sep;55 Suppl B:70-3 (1994)
Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements.
Brain Res., May;646(2):217-22 (1994)
Dr. Michael Knable M